CT UK Capital and Income Investment: Snapshot of Top Ten Holdings and Sector Analysis

CT UK Capital and Income Investment Trust, a distinguished player in finance, recently brought to light its portfolio standings as of March 31, 2025. The impressive portfolio reveals a diverse spectrum of holdings and sector distribution and is accessible on the Company’s official website.

Headlining the top ten holdings is AstraZeneca, the global, science-led biopharmaceutical giant. AstraZeneca maintains a solid 5.8% position, followed closely by OSB Group and Intermediate Capital, both at 5.6%. The list continues with RELX at 5.4%, Unilever at 5.2%, Beazley with 5.1%, LondonMetric Property at 4.1%, Legal & General Group at 3.8%, and Shell and Burford Capital both holding 3.5%. This impressive conscription amasses to a whopping 47.6% of the portfolio.

Revealing a stable condition, the net gearing of the Investment Trust rests at 5.0%, indicated by the RNS, the authoritative news service of the London Stock Exchange, and the approved Primary Information Provider in the United Kingdom by Financial Conduct Authority.